{"commentary":{"count":22,"free_build_floor":8,"listing_floor":3,"by_channel":{"x_thread":18,"youtube":2,"podcast":2},"note":"Indexed podcasts, YouTube videos and X posts that name this trial. A report screens them, searches for more and cites what clinicians said when it is built."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT03837821\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's public preview; the full report is still bought."},"name":"CLONEVO","nct_id":"NCT03837821","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=clonevo-nct03837821. The price is fixed at order. We build the report after the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1250,"size":"standard","size_rule":"Standard: 13–40 commentary sources"},"registry":{"acronym":"CLONEVO","arms":[{"description":"Abemaciclib 200 mg oral, every 12 hours","label":"All Subjects","type":"EXPERIMENTAL"}],"collaborators":["Eli Lilly and Company"],"completion_date":{"date":"2026-12","type":"ESTIMATED"},"conditions":["Bladder Cancer"],"enrollment":{"count":20,"type":"ACTUAL"},"has_results":false,"interventions":[{"name":"Abemaciclib","type":"DRUG"}],"last_update":"2025-11-18","lead_sponsor":"Weill Medical College of Cornell University","official_title":"A Window-of-opportunity Trial of Abemaciclib Followed by Radical Cystectomy in Patients With Platinum-ineligible Urothelial Carcinoma to Evaluate CDK4/6-dependent Phosphorylation of Pocket Proteins and Clonal Evolution Dynamics","overall_status":"ACTIVE_NOT_RECRUITING","phases":["EARLY_PHASE1"],"primary_completion_date":{"date":"2024-07-02","type":"ACTUAL"},"primary_outcomes":[{"measure":"Change in cell-cycle dynamics between pre- and post-Abemaciclib tumor samples","timeFrame":"At baseline and post 4 week treatment"}],"references":[],"start_date":{"date":"2019-02-05","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"(CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer","url":"https://clinicaltrials.gov/study/NCT03837821"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"2.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/clonevo-nct03837821"}